Shortened platelet lifespan in patients with hydrocephalus and ventriculojugular shunts: results of preliminary attempts at correction.
D001241:Aspirin / Q000627:therapeutic use; D001780:Blood Coagulation Tests; D001792:Blood Platelets / Q000378:metabolism; D002404:Catheterization / Q000009:adverse effects; D002552:Cerebral Ventricles / Q000601:surgery; D002557:Cerebrospinal Fluid Shunts / Q000009:adverse effects*; D002675:Child, Preschool; D002859:Chromium Isotopes; D004176:Dipyridamole / Q000627:therapeutic use; D004211:Disseminated Intravascular Coagulation / Q000209:etiology*; D006325:Heart Atria / Q000601:surgery; D006801:Humans; D006849:Hydrocephalus / Q000628:therapy*; D007223:Infant; D010973:Platelet Adhesiveness; D013923:Thromboembolism / Q000188:drug therapy / Q000209:etiology
D002859:Chromium Isotopes; D004176:Dipyridamole; D001241:Aspirin